GlassScriptPhysician profile
Richard Williams
NPI 1467457390
$2,120.61
in general payments reported to CMS, 2019-2025
22 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $327 · 2021: $414 · 2022: $291 · 2023: $236 · 2024: $124 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.56 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.64 | 2019-2025 | Orilissa, Lo Loestrin Fe, Oriahnn |
| Hologic Sales and Service, LLC | $292.38 | 2022-2024 | Acessa Provu System |
| Therapeuticsmd, INC. | $127.11 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $110.51 | 2024-2025 | |
| Novo Nordisk INC | $93.77 | 2022-2024 | Wegovy |
| Sage Therapeutics, LLC | $87.89 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $76.92 | 2019-2020 | |
| Allergan, INC. | $45.64 | 2019-2020 | |
| Exeltis, USA INC. | $41.42 | 2025 | Slynd |
| Pfizer INC. | $40.83 | 2021-2024 | |
| Lupin INC. | $35.67 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $35.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.71 | 2019 | |
| Boston Scientific Corporation | $28.75 | 2025 | Bulkamid |
| Avion Pharmaceuticals | $27.19 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $23.29 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $18.67 | 2019 | |
| Duchesnay USA Incorporated | $16.98 | 2019 | |
| Coloplast Corp | $16.32 | 2021 | |
| Ethicon US, LLC | $14.83 | 2025 | Enseal |
| Stryker Corporation | $14.21 | 2025 | Gamma |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.